Existing predictive markers, including the expression of PD-L1 in tumor cells (22), tumor mutational burden, and gene mutation repair ability (23), and the expression level of PD-1 in tumor immune infiltrating CD8+ T cells (7) have limited value. The gene discussed is CD274; the disease is neoplasm.